- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/10 - Expectorants
Patent holdings for IPC class A61P 11/10
Total number of patents in this class: 138
10-year publication summary
|
9
|
6
|
5
|
8
|
6
|
25
|
11
|
7
|
9
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 173 |
9 |
| Vertex Pharmaceuticals Incorporated | 1568 |
8 |
| Pulmatrix, Inc. | 23 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 862 |
4 |
| Yamaha Corporation | 4075 |
3 |
| Chengdu Shibeikang Biomedical Technology Co., Ltd. | 19 |
3 |
| The Procter & Gamble Company | 22146 |
2 |
| Novartis AG | 11254 |
2 |
| Chiesi Farmaceutici S.p.A. | 958 |
2 |
| Daiichi Sankyo Company, Limited | 1864 |
2 |
| Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH | 133 |
2 |
| Pulmatrix Operating Company, Inc. | 45 |
2 |
| Sun Yat-sen University | 634 |
2 |
| URGO Recherche Innovation et Developpement | 294 |
2 |
| Guangzhou Institute of Respiratory Disease | 10 |
2 |
| Neilos S.r.l. | 84 |
2 |
| Czap Research and Development, LLC | 10 |
2 |
| HC Synthetic Pharmaceutical Co., Ltd | 12 |
2 |
| Hunan Aidalun Technology Co., Ltd. | 4 |
2 |
| Pathios Therapeutics Limited | 20 |
2 |
| Other owners | 79 |